# BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors

> **NCT06368960** · PHASE1 · UNKNOWN · sponsor: **InnoBM Pharmaceuticals Co., Ltd.** · enrollment: 36 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **RADIATION:** Radiotherapy
- **DRUG:** BM201 injection

## Key facts

- **NCT ID:** NCT06368960
- **Lead sponsor:** InnoBM Pharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-07
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06368960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06368960, "BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06368960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*